Akso Health Group Past Earnings Performance

Past criteria checks 0/6

Akso Health Group has been growing earnings at an average annual rate of 29%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 15.4% per year.

Key information

29.0%

Earnings growth rate

36.0%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate15.4%
Return on equity-6.6%
Net Margin-375.2%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Estimating The Intrinsic Value Of Akso Health Group (NASDAQ:AHG)

Nov 15
Estimating The Intrinsic Value Of Akso Health Group (NASDAQ:AHG)

Akso Health receives non-compliance notice from Nasdaq

Aug 17

Xiaobai Maimai Eyes Cancer Treatment As E-Commerce Pivot Sputters

Oct 26

Hexindai reports 1H results

Dec 21

Revenue & Expenses Breakdown

How Akso Health Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:AHG Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 242-990
31 Dec 232-13130
30 Sep 232-18170
30 Jun 238-16160
31 Mar 2313-13160
30 Sep 22186-40
30 Jun 2212100
31 Mar 226-430
31 Dec 213-20220
30 Sep 211-23330
30 Jun 211-27310
31 Mar 210-420
31 Dec 20-2-3140
30 Sep 208-88480
30 Jun 207-73380
31 Mar 207-47230
31 Dec 19-43-51-30
30 Sep 1916-24460
30 Jun 1915-31530
31 Mar 194-8110
31 Dec 188520580
30 Sep 1812656570
30 Jun 1814486420
31 Mar 1810765310
31 Dec 178753270
30 Sep 175027190
30 Jun 173416150
31 Mar 17239130
31 Dec 16196110
30 Sep 16176100
30 Jun 1614590
31 Mar 1612480
31 Mar 155050

Quality Earnings: AHG is currently unprofitable.

Growing Profit Margin: AHG is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AHG is unprofitable, but has reduced losses over the past 5 years at a rate of 29% per year.

Accelerating Growth: Unable to compare AHG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AHG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).


Return on Equity

High ROE: AHG has a negative Return on Equity (-6.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 22:42
End of Day Share Price 2024/12/27 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Akso Health Group is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joshua VogelSidoti & Company, LLC